Live feed08:05:00·52dPRReleasevia QuantisnowSCIENTURE Broadens Commercial Access for REZENOPY™, Highest-Dose FDA-Approved Naloxone Nasal Spray, Through GPO Agreements Reaching Over 5,000 U.S. InstitutionsByQuantisnow·Wall Street's wire, on your screen.SCNX· Scienture Holdings Inc.Health Care
